Author: Maslow, Joel
Title: GeneOne Life Science Document date: 2018_10_26
ID: w7hf3kji_19
Snippet: Simply: collaboration, quality, and safety. Underlying GeneOne’s success is a strong sense of collaboration with the physicians (and through them their patients) for whom our therapeutics are targeted, with the academics, commercial partners, and regulators on whom we rely throughout drug development, and, internally, with all members of GeneOne whose input to the development process is highly valued. GeneOne’s central tenets are, however, qu.....
Document: Simply: collaboration, quality, and safety. Underlying GeneOne’s success is a strong sense of collaboration with the physicians (and through them their patients) for whom our therapeutics are targeted, with the academics, commercial partners, and regulators on whom we rely throughout drug development, and, internally, with all members of GeneOne whose input to the development process is highly valued. GeneOne’s central tenets are, however, quality and safety. Quality starts with the approach to drug development, from manufacture, pre-clinical development, through clinical trial design and conduct. Above all else is that GeneOne is committed to safety and safety must be an overarching consideration at all stages as our new drugs are brought into and through development.
Search related documents:
Co phrase search for related documents- clinical trial design and development process: 1, 2, 3
- clinical trial design and drug development: 1, 2, 3, 4, 5, 6, 7
- clinical trial design and drug development approach: 1
- clinical trial design and new drug: 1, 2, 3, 4, 5, 6, 7
- clinical trial design and physician collaboration: 1
- commercial partner and new drug: 1
- development bring and drug development: 1, 2, 3, 4
- development process and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- development process and drug development approach: 1, 2, 3, 4, 5
- development process and new drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- development process and pre clinical development: 1
- drug development and new drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- drug development and pre clinical development: 1, 2, 3, 4, 5
- drug development approach and new drug: 1, 2, 3, 4, 5, 6
- new drug and pre clinical development: 1
Co phrase search for related documents, hyperlinks ordered by date